[Federal Register Volume 83, Number 82 (Friday, April 27, 2018)]
[Notices]
[Page 18555]
[FR Doc No: 2018-08968]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-9977-16-Region 10]

Proposed Issuance of NPDES General Permit for Hydroelectric
Facilities Within the State of Idaho (IDG360000)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of proposed issuance of NPDES General Permit and request
for public comment.

-----------------------------------------------------------------------

SUMMARY: The Director, Office of Water and Watersheds, Environmental
Protection Agency (EPA) Region 10, is proposing to issue a National
Pollutant Discharge Elimination System (NPDES) General Permits for
Hydroelectric Facilities discharging to waters within the State of
Idaho (Permit No. IDG360000). As proposed, the hydroelectric general
permit would protect surface waters from discharges of oil, grease and
alterations to pH from facility and equipment outfalls and minimize the
impacts of the cooling water intake structures to fish and aquatic
organisms.

DATES: Comments must be received by June 11, 2018.

ADDRESSES: Comments on the draft General Permit should be sent to
Director, Office of Water and Watersheds; USEPA Region 10; 1200 Sixth
Avenue, Suite 155, OWW-191; Seattle, WA 98101 and may also be submitted
by fax to<PHONE_NUMBER> or electronically to [email protected].
    Comments on the draft 401Certification should be sent to Loren
Moore, Idaho Department of Environmental Quality, 1410 N. Hilton,
Boise, Idaho 83706 or electronically to [email protected].

FOR FURTHER INFORMATION CONTACT: Permit documents may be found on the
EPA Region 10 website at: https://www.epa.gov/npdes-permits/draft-npdes-general-permit-hydroelectric-generating-facilities-idaho. Copies
of the draft general permit and Fact Sheet are also available upon
request. Requests may be made to Audrey Washington at<PHONE_NUMBER> or
to Dru Keenan at<PHONE_NUMBER>. Requests may also be electronically
mailed to: [email protected], or [email protected].

SUPPLEMENTARY INFORMATION:

I. General Information

    As proposed, the hydroelectric general permit would authorize five
types of discharges from hydroelectric facilities: Equipment related
cooling water, equipment and floor drain water, certain maintenance
related waters, maintenance-related water during flood/high water
events and backwash strainer water, and combinations of the preceding
discharges. The general permit establishes notification requirements,
permit eligibility requirements, effluent limitations, standards,
prohibitions, best management practice plans, and impingement and
entrainment prevention plans per 316(b) of the CWA. A description of
the basis for the conditions and requirements of the draft general
permit is given in the Fact Sheet. Owners and/or operators of
hydroelectric generating facilities with these discharges, including
those facilities currently authorized to discharge under individual
permits, are eligible to apply for coverage. Facilities will receive a
written notification from the EPA whether permit coverage and
authorization to discharge under the general permit is approved. The
general permit does not cover new sources as defined under 40 CFR
122.2.

II. Other Legal Requirements

    This action is not a significant regulatory action and was
therefore not submitted to the Office of Management and Budget (OMB)
for review under Executive Orders 12866, Regulatory Planning and
Review, and 13563, Improving Regulation and Regulatory Review. State
certification under section 401 of the CWA, compliance with Endangered
Species Act, Essential Fish Habitat, Paperwork Reduction Act, and other
requirements are discussed in the Fact Sheet to the proposed permit.

    Dated: April 13, 2018.
Daniel D. Opalski,
Director, Office of Water and Watersheds, Region 10.
[FR Doc. 2018-08968 Filed 4-26-18; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register Volume 82, Number 189 (Monday, October 2, 2017)]
[Notices]
[Pages 45856-45858]
[FR Doc No: 2017-21018]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-5776]

Equivalence of Complex Products; Public Workshop; Request for
Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is
announcing the following public workshop entitled ``Demonstrating
Equivalence of Generic Complex Drug Substances and Formulations:
Advances in Characterization and In Vitro Testing.'' The purpose of the
workshop is to share FDA's current experiences on the evaluation and
characterization of critical quality attributes for complex drug
substances (e.g. polymeric and naturally derived substances and
peptides) and formulations (e.g. liposomes, emulsions, suspensions, and
polymeric inserts); discuss current and future innovative approaches
for the development and regulatory review of equivalent complex drug
products; obtain input from various stakeholders on how to conduct and
assess critical quality attribute measurements to demonstrate
equivalence of complex drug products; and request comments on these
topics.

DATES: The public workshop will be held on October 6, 2017, from 8:30
a.m. to 4:30 p.m. Submit either electronic or written comments on this
public workshop by November 10, 2017. See the SUPPLEMENTARY INFORMATION
section for registration date and information.

ADDRESSES: The public workshop will be held at FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room
(Rm. 1503 B+C), Silver Spring, MD 20993-0002. Entrance for the public
workshop participants (non-FDA employees) is through Building 1 where
routine security check procedures will be performed. For parking and
security information, please refer to https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.
    You may submit comments as follows. Please note that late, untimely
filed comments will not be considered. Electronic comments must be
submitted on or before November 10, 2017. The https://www.regulations.gov electronic filing system will accept comments until
midnight Eastern Time at the end of November 10, 2017. Comments
received by mail/hand delivery/courier (for written/paper submissions)
will be considered timely if they are postmarked or the delivery
service acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2017-N-5776 for ``Demonstrating Equivalence of Generic Complex Drug
Substances and Formulations: Advances in Characterization and In Vitro
Testing.'' Received comments, those filed in a timely manner (see
ADDRESSES), will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on

https://www.regulations.gov. Submit both copies to the Dockets
Management Staff. If you do not wish your name and contact information
to be made publicly available, you can provide this information on the
cover sheet and not in the body of your comments and you must identify
this information as ``confidential.'' Any information marked as
``confidential'' will not be disclosed except in accordance with 21 CFR
10.20 and other applicable disclosure law. For more information about
FDA's posting of comments to public dockets, see 80 FR 56469, September
18, 2015, or access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Xiaohui Jiang, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 75, Rm. 4716, Silver Spring, MD 20993, 240-402-
4468<EMAIL_ADDRESS>or Darby Kozak, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 75, Rm. 4710, Silver Spring, MD 20993, 240-402-
2647<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    In July 2012, Congress passed the Generic Drug User Fee Amendments
(GDUFA) (Title III of the Food and Drug Administration Safety and
Innovation Act (Pub. L. 112-144)). GDUFA is designed to enhance public
access to safe, high-quality generic drugs and reduce costs to
industry. To support this goal, FDA agreed in the GDUFA commitment
letter to work with industry and interested stakeholders on identifying
regulatory science research priorities specific to generic drugs for
each fiscal year covered by GDUFA. The commitment letter outlines FDA's
performance goals and procedures under the GDUFA program for the years
2012 to 2017. The commitment letter can be found at https://www.fda.gov/downloads/ForIndustry/UserFees/GenericDrugUserFees/UCM282505.pdf.
    In the Regulatory Science section of the GDUFA Commitment Letter,
FDA outlined its plans to advance regulatory science, including
research to support the development of guidance and policy that
clarifies the ANDA pathway for complex drug products. This regulatory
science research includes but is not limited to: (1) Assessing
innovative analytical methods and procedures for characterizing the
active ingredient sameness and pharmaceutical equivalence of complex
drug substances, such as peptides and naturally derived substances, and
(2) developing and evaluating new techniques to measure the critical
quality attributes of complex formulations, such as liposomes,
emulsions, suspensions, and polymeric inserts, with the goal of
providing robust in vitro alternatives to in vivo bioequivalence
studies, and (3) developing and evaluating critical quality attributes
for complex drug-device combination products. To facilitate
communication of recent advances in this regulatory science, including
those supported by GDUFA funds, FDA plans to hold a public workshop on
new analytical methods and assessment criteria for demonstrating the
equivalence of complex drug substances and formulations.

II. Topics for Discussion at the Public Workshop

    The purposes of the workshop are to:
    1. Share FDA's current experiences on the evaluation and
characterization of critical quality attributes for complex drug
substances (e.g. polymeric and naturally derived substances and
peptides) and formulations (e.g. liposomes, emulsions, suspensions, and
polymeric inserts);
    2. Discuss current and future innovative approaches for the
development and regulatory review of equivalent complex drug products;
    3. Obtain input from various stakeholders on how to conduct and
assess critical quality attribute measurements to demonstrate
equivalence of complex drug products; and
    4. Request comments on these topics.
    The scope of the workshop covers the current status, from an
academic, industry, and regulatory perspective, of methods for
assessing the pharmaceutical equivalence of complex drug substances and
the bioequivalence of complex generic drug product formulations.
    Complex drug substances and formulations present unique development
and regulatory challenges for generic drugs as establishing equivalence
may not be straightforward by conventional practices. New and
innovative analytical and statistical approaches may overcome these
hurdles and thereby reduce product development time and cost, and
inform regulatory decisions. For example, new high resolution
analytical methods and advanced statistical models can provide better
understanding of the complex structure, and greater confidence of
structural sameness, needed for demonstrating the pharmaceutical
equivalence of a generic peptide, carbohydrate, or other naturally-
sourced complex drug substance. In the same fashion, new and innovative
in vitro characterization methods can provide an accurate measure of
the critical quality attributes of generic liposomal, emulsion,
suspension, or polymeric matrix drug products. These in vitro tests can
often be used to support a demonstration of bioequivalence, in lieu of
in vivo studies, depending, among other factors, on the sensitivity,
robustness and/or correlation of these in vitro tests to the product
performance. The focus of this public workshop is on the evaluation of
new analytical and statistical methods for demonstrating equivalence of
complex products, including discussing the areas in which these methods
can contribute significantly, how and when the methods should be
conducted and evaluated, and inherent scientific challenges.
    Public input will improve FDA's current understanding of present
and future methods available for evaluating complex product
equivalence. The knowledge gained from, and consensus reached, through
this workshop will be summarized and disseminated to the scientific
community by publication(s).
    FDA seeks input from the public on when, where, and how to utilize
new methods for development of equivalent complex drug products and in
the regulatory review of pharmaceutical equivalence and bioequivalence.
Specific topics to be addressed include:
    1. Identifying the areas in which new in vitro analytical and
statistical methods can contribute to the development of equivalent
complex products and regulatory evaluation of pharmaceutical
equivalence and bioequivalence;
    2. Discussing how in vitro testing for demonstrating complex
product equivalence should be conducted and evaluated; and
    3. Addressing the scientific challenges in assessing critical
quality attributes of complex products and in developing new analytical
methods for demonstrating complex product equivalence.

III. Participating in the Public Workshop

    Registration: Persons interested in attending this public workshop
must register online at https://survey.co1.qualtrics.com/jfe/form/SV_6X23XS8WXHtfWAJ. Please provide complete contact information for
each attendee, including name, title, affiliation, address, email, and
telephone.
    Registration is free and based on space availability, with priority
given to early registrants. Persons interested in attending this public
workshop must register by October 2, 2017, midnight, Eastern Time.
Early registration is recommended because seating is limited;
therefore, FDA may limit the number of participants from each
organization.
    If you need special accommodations due to a disability, please
contact Xiaohui Jiang (see FOR FURTHER INFORMATION CONTACT) no later
than October 2, 2017.
    Streaming Webcast of the public workshop: This public workshop will
also be webcast. A live webcast of this workshop will be viewable at
https://collaboration.fda.gov/complexgenericdrugs/ on the day of the
workshop.
    If you have never attended a Connect Pro event before, test your
connection at https://collaboration.fda.gov/common/help/en/support/meeting_test.htm. To get a quick overview of the Connect Pro program,
visit https://www.adobe.com/go/connectpro_overview. FDA has verified
the Web site addresses in this document, as of the date this document
publishes in the Federal Register, but Web sites are subject to change
over time.
    Transcripts: Please be advised that as soon as a transcript of the
public workshop is available, it will be accessible at https://www.regulations.gov. It may be viewed at the Dockets Management Staff
(see ADDRESSES). A link to the transcript will also be available on the
Internet at https://www.fda.gov/drugs/newsevents/ucm552461.htm.

    Dated: September 26, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-21018 Filed 9-29-17; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 79, Number 121 (Tuesday, June 24, 2014)]
[Notices]
[Page 35821]
[FR Doc No: 2014-14661]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Submission for OMB Review; Comment Request

Upon Written Request, Copies Available From: Securities and Exchange
Commission, Office of Investor Education and Advocacy, Washington, DC
20549-0213.

Extension:
    Rule 203-2 and Form ADV-W; OMB Control No. 3235-0313, SEC File
No. 270-40.

    Notice is hereby given that, pursuant to the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.), the Securities and Exchange
Commission (``Commission'') has submitted to the Office of Management
and Budget (``OMB'') a request for extension of the previously approved
collection of information discussed below.
    The title for the collection of information is ``Rule 203-2 (17 CFR
275.203-2) and Form ADV-W (17 CFR 279.2) under the Investment Advisers
Act of 1940 (15 U.S.C. 80b).'' Rule 203-2 under the Investment Advisers
Act of 1940 establishes procedures for an investment adviser to
withdraw its registration with the Commission. Rule 203-2 requires
every person withdrawing from investment adviser registration with the
Commission to file Form ADV-W electronically on the Investment Adviser
Registration Depository (``IARD''). The purpose of the information
collection is to notify the Commission and the public when an
investment adviser withdraws its pending or approved SEC registration.
Typically, an investment adviser files a Form ADV-W when it ceases
doing business or when it is ineligible to remain registered with the
Commission.
    The potential respondents to this information collection are all
investment advisers registered with the Commission. The Commission has
estimated that compliance with the requirement to complete Form ADV-W
imposes a total burden of approximately 0.75 hours (45 minutes) for an
adviser filing for full withdrawal and approximately 0.25 hours (15
minutes) for an adviser filing for partial withdrawal. Based on
historical filings, the Commission estimates that there are
approximately 600 respondents annually filing for full withdrawal and
approximately 200 respondents annually filing for partial withdrawal.
Based on these estimates, the total estimated annual burden would be
500 hours ((600 respondents x .75 hours) + (200 respondents x .25
hours)).
    Rule 203-2 and Form ADV-W do not require recordkeeping or records
retention. The collection of information requirements under the rule
and form are mandatory. The information collected pursuant to the rule
and Form ADV-W are filings with the Commission. These filings are not
kept confidential. An agency may not conduct or sponsor, and a person
is not required to respond to, a collection of information unless it
displays a currently valid control number.
    The public may view the background documentation for this
information collection at the following Web site, www.reginfo.gov.
Comments should be directed to: (i) Desk Officer for the Securities and
Exchange Commission, Office of Information and Regulatory Affairs,
Office of Management and Budget, Room 10102, New Executive Office
Building, Washington, DC 20503, or by sending an email to<EMAIL_ADDRESS>and (ii) Thomas Bayer, Chief Information Officer,
Securities and Exchange Commission, c/o Remi Pavlik-Simon, 100 F Street
NE., Washington, DC 20549 or send an email to<EMAIL_ADDRESS>
Comments must be submitted to OMB within 30 days of this notice.

    Dated: June 18, 2014.
Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2014-14661 Filed 6-23-14; 8:45 am]
BILLING CODE 8011-01-P


SI  GASEOUS FUEL  BY HP  10/ 24 SumOfSumOSumOfSumOSumOfSumOSumOfSumOSumOfSumOSumOfSumOSumOfSumOSumOfSumO 0 0 0 0 271 0 1657 2284 SumOfSumOSumOfSumOSumOfSumOSumOfSumOSumOfSumOSumOfSumOSumOfSumOSumOfSumO 63130 28542 9853 8226 2787 1533 2961 3775 SumOfSumOSumOfSumOSumOfSumOf1996 3000+ 790 599 147


    Additional EPA Response to February 13 Comments from Interagency Review       EPA Proposed Rule, "Control of Air Pollution from Motor Vehicles:       Tier 3 Motor Vehicle Emission and Fuel Standards," RIN 2060-AQ86

The February 13 comments asked about what analysis could be done in the short term to address OMB's interest in better understanding the effects of the proposed Tier 3 fuel sulfur standards in isolation of the proposed Tier 3 vehicle standards.

As we noted in our prior response, we analyzed the combined fuel and vehicle program, in keeping with the fundamental principles of the Tier 3 program: that vehicles and fuels should be analyzed as an integrated system, as has been successfully done in the mobile source emission control program for over a decade; and there should be a harmonized national vehicle program that establishes a comprehensive approach to regulating motor vehicles (both greenhouse gases and non-greenhouse gases), as requested by the Presidential Memo of May 2010.

As described in detail in the draft proposal and in the scientific literature, there is a first-order relationship between fuel sulfur content and the efficiency of modern three-way catalytic converters.  The Tier 3 proposal addresses the stringency of exhaust gas standards and fuel sulfur level as a system because that is what the scientific literature tells us -- the two are strongly linked.

With respect to the harmonized national program goal, the Administration has informed EPA in the past several years that development of federal vehicle standards that are closely coordinated with standards adopted by the States is critically important for the automotive industry to provide the opportunity for a nationally harmonized set of standards.  The proposed Tier 3 combined fuel sulfur and vehicle standards are designed to both significantly reduce emissions to protect public health and welfare and to enable closely coordinated national and state vehicle standards.

While it is not possible to identify the air quality impacts, health effects, or benefits of a fuel sulfur program that would be independent of a vehicle program, the proposal contains a significant amount of analysis that distinguishes the impacts of fuel sulfur on the existing fleet (pre-Tier 3) from the impacts of the vehicle and fuel sulfur standards for new Tier 3 vehicles.

For example, Section III.B. of the preamble presents these emission impacts both in total and separately, as excerpted below.

Table III-2 Projected NOX Reductions from Tier 3 Program (Annual U.S. Tons)

2017 2030 Total reduction 284,381 524,790 Reduction from pre-Tier 3 fleet due to sulfur standard 264,653 66,286 Reduction from Tier 3 fleet due to vehicle and sulfur standards  19,728 458,504 Percent reduction in onroad NOX emissions 8% 28%

Table III-3 Projected VOC Reductions from Tier 3 Program (Annual U.S. Tons)

2017 2030 Total reduction 44,782 226,028 Reduction from pre-Tier 3 fleet due to sulfur standard  39,561 13,739 Reduction from Tier 3 fleet due to vehicle and sulfur standards  5,222 212,289

                                                                        Exhaust                                                                          41,433                                                                         168,264                                                                    Evaporative                                                                            3,349                                                                          57,764 Percent reduction in onroad VOC emissions 3% 23%

Tables III-2 and III-3 from the preamble show that in 2017, the impact of fuel sulfur standards on the existing fleet of Tier 2 and pre-Tier 2 vehicles is quite significant in terms of NOx and VOC reductions.  These same tables show that when combined with the proposed Tier 3 vehicle standards and significant vehicle fleet turn-over to Tier 3 vehicles by 2030, the impact of both Tier 3 fuel sulfur standards and Tier 3 vehicle standards is also significant in terms of actual projected emissions reductions.  Table III-4 shows the impacts in 2017 and 2030 on carbon monoxide emissions.

Table III-4 Projected CO Reductions from Tier 3 Program (Annual U.S. Tons)

2017 2030 Total reduction 746,683 5,765,362 Reduction from pre-Tier 3 fleet due to sulfur standard 608,502 139,074 Reduction from Tier 3 fleet due to vehicle and sulfur standards 138,181 5,626,288 Percent reduction in onroad CO emissions 4% 30%

In addition to the impacts of fuel sulfur standards alone on the pre-Tier 3 fleet and combined fuel sulfur standards and vehicle standards for the Tier 3 fleet presented in Tables III-2 through III-4 of the preamble, EPA has also conducted air quality modeling for 2017 in order to understand the immediate impacts of the Tier 3 proposal.  The air quality impacts in 2017 are mostly due to the impact of the fuel sulfur program on the existing fleet, reflecting the corresponding reduction in emissions.

The proposal would meaningfully reduce ozone concentrations as early as 2017 (the first year of the program), and even more significantly in 2030.  We also project that the Tier 3 standards would reduce ambient PM2.5 concentrations.  On a nationwide, population - weighted average basis the Tier 3 standards are projected to reduce ozone and 24-hour PM2.5 design values by 0.47 ppb and 0.01 ug/m[3] in 2017 and by 1.55 ppb and 0.14 ug/m[3] in 2030.  These air quality modeling results are presented in detail in preamble Section III.C. and RIA Chapter 7.  Finally, we performed an illustrative analysis of monetized impacts associated with the proposal in 2017 (preamble Section VIII.E and RIA Chapter 8.1.4).

The proposal package also presents the costs of the vehicle and sulfur programs both separately and combined, for both 2017 and 2030.  For example, the RIA Executive Summary presents the following tables.  (Similar material is also presented in preamble Section VII and RIA Chapters 2, 5, and 8).

Table ES-1 Annual Vehicle Technology Costs, 2010$ Year                     Vehicle Exhaust Emission Control Costs                                   ($Million)                   Vehicle Evaporative Emission Control Costs                                   ($Million)                            Facility Costs ($Million)                               Total Vehicle Costs                                   ($Million) 2017                                      $634                                       $71                                       $4                                      $709 2030                                     $1,790                                      $253                                       $4                                     $2,047

Table ES-2 Annual Fuel Costs, 2010$ Year                      Fuel Sulfur Control Costs ($Million) 2017                                     $1,289 2030                                     $1,320                                                                                Table ES-3: Total Annual Vehicle and Fuel Control Costs, 2010$ Year                 Total Vehicle and Fuel Control Costs ($Million) 2017                                     $1,999 2030                                     $3,367

In these ways, the Tier 3 proposal presents substantial and transparent analysis of the impacts of the vehicle and sulfur standards.


[Federal Register Volume 84, Number 126 (Monday, July 1, 2019)]
[Notices]
[Pages 31311-31312]
[FR Doc No: 2019-13934]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CD19-8-000]

Notice of Preliminary Determination of a Qualifying Conduit
Hydropower Facility and Soliciting Comments and Motions To Intervene;
InPipe Energy

    On June 13, 2019, InPipe Energy filed a notice of intent to
construct a qualifying conduit hydropower facility, pursuant to section
30 of the Federal Power Act (FPA). The proposed Carson Water Recycling
Facility Hydroelectric Project would have an installed capacity of 130
kilowatts (kW), and would be located along an existing 14-inch pipeline
within the Juanita Millender-McDonald Carson Regional Water Recycling
Plant in the city of Carson, Los Angeles County, California.
    Applicant Contact: Gregg Semler, InPipe Energy, 222 NW 8th Ave.,
Portland, OR 97209, Phone No.<PHONE_NUMBER>, Email:
<EMAIL_ADDRESS>    FERC Contact: Christopher Chaney, Phone No.<PHONE_NUMBER>, Email:
<EMAIL_ADDRESS>    Qualifying Conduit Hydropower Facility Description: The proposed
project would consist of: (1) One 130-kW turbine-generator unit; (2) a
12-inch pipeline transporting water from the existing 14-inch pipeline
to the generator, and returning it to the mainline; and (3) appurtenant
facilities. The proposed project would have an estimated annual
generation of up to 575 megawatt-hours.
    A qualifying conduit hydropower facility is one that is determined
or deemed to meet all of the criteria shown in the table below.

                          Table 1--Criteria for Qualifying Conduit Hydropower Facility
----------------------------------------------------------------------------------------------------------------
                                                                                Satisfies (Y/
              Statutory provision                                   Description                          N)
----------------------------------------------------------------------------------------------------------------
FPA 30(a)(3)(A)................................  The conduit the facility uses is a tunnel, canal,            Y
                                                  pipeline, aqueduct, flume, ditch, or similar
                                                  manmade water conveyance that is operated for
                                                  the distribution of water for agricultural,
                                                  municipal, or industrial consumption and not
                                                  primarily for the generation of electricity.
FPA 30(a)(3)(C)(i).............................  The facility is constructed, operated, or                    Y
                                                  maintained for the generation of electric power
                                                  and uses for such generation only the
                                                  hydroelectric potential of a non-federally owned
                                                  conduit.
FPA 30(a)(3)(C)(ii)............................  The facility has an installed capacity that does             Y
                                                  not exceed 40 megawatts.
FPA 30(a)(3)(C)(iii)...........................  On or before August 9, 2013, the facility is not             Y
                                                  licensed, or exempted from the licensing
                                                  requirements of Part I of the FPA.
----------------------------------------------------------------------------------------------------------------

    Preliminary Determination: The proposed Carson Water Recycling
Facility Hydroelectric Project will not interfere with the primary
purpose of the conduit, which is used for the City's non-potable
municipal water supply distribution system, which feeds commercial,
industrial, and residential customers. Therefore, based upon the above
criteria, Commission staff preliminarily determines that the proposal
satisfies the requirements for a qualifying conduit hydropower
facility, which is not required to be licensed or exempted from
licensing.
    Comments and Motions to Intervene: Deadline for filing comments
contesting whether the facility meets the qualifying criteria is 30
days from the issuance date of this notice.
    Deadline for filing motions to intervene is 30 days from the
issuance date of this notice.
    Anyone may submit comments or a motion to intervene in accordance
with the requirements of Rules of Practice and Procedure, 18 CFR
385.210 and 385.214. Any motions to intervene must be received on or
before the specified deadline date for the particular proceeding.
    Filing and Service of Responsive Documents: All filings must (1)
bear in all capital letters the ``COMMENTS CONTESTING QUALIFICATION FOR
A CONDUIT HYDROPOWER FACILITY'' or ``MOTION TO INTERVENE,'' as
applicable; (2) state in the heading the name of the applicant and the
project number of the application to which the filing responds; (3)
state the name, address, and telephone number of the person filing; and
(4) otherwise comply with the requirements of sections 385.2001 through
385.2005 of the Commission's regulations.\1\ All comments contesting
Commission staff's preliminary determination that the facility meets
the qualifying criteria must set forth their evidentiary basis.
---------------------------------------------------------------------------

    \1\ 18 CFR 385.2001-2005 (2018).
---------------------------------------------------------------------------

    The Commission strongly encourages electronic filing. Please file
motions to intervene and comments using the Commission's eFiling system
at http://www.ferc.gov/docs-filing/efiling.asp. Commenters can submit
brief comments up to 6,000 characters, without prior registration,
using the eComment system at http://www.ferc.gov/docs-filing/ecomment.asp. You must include your name and contact information at the
end of your comments. For assistance, please contact FERC Online
Support at<EMAIL_ADDRESS>(866) 208-3676 (toll free), or
(202) 502-8659 (TTY). In lieu of electronic filing, please send a paper
copy to: Secretary, Federal Energy Regulatory Commission, 888 First
Street NE, Washington, DC 20426.

A copy of all other filings in reference to this application must be
accompanied by proof of service on all persons listed in the service
list prepared by the Commission in this proceeding, in accordance with
18 CFR 4.34(b) and 385.2010.
    Locations of Notice of Intent: Copies of the notice of intent can
be obtained directly from the applicant or such copies can be viewed
and reproduced at the Commission in its Public Reference Room, Room 2A,
888 First Street NE, Washington, DC 20426. The filing may also be
viewed on the web at http://www.ferc.gov/docs-filing/elibrary.asp using
the ``eLibrary'' link. Enter the docket number (i.e., CD19-8) in the
docket number field to access the document. For assistance, call toll-
free 1-866-208-3676 or email<EMAIL_ADDRESS>For TTY, call
(202) 502-8659.

    Dated: June 24, 2019.
Kimberly D. Bose,
Secretary.
[FR Doc. 2019-13934 Filed 6-28-19; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: May 8, 2009 (Volume 74, Number 88)]
[Proposed Rules]
[Page 21564-21565]
[DOCID:fr08my09-13]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 165

[Docket No. USCG-2008-1017]
RIN 1625-AA11

Regulated Navigation Areas; Bars Along the Coasts of Oregon and
Washington

AGENCY: Coast Guard, DHS.

ACTION: Proposed rule; notice of reopening of comment period; request
for comments.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard announces the reopening of the comment period
to receive comments on the notice of proposed rulemaking (NPRM)
entitled ``Regulated Navigation Areas; Bars Along the Coasts of Oregon
and Washington'' that was published in the Federal Register on February
12, 2009. As stated in the NPRM, the Coast Guard proposes to establish
Regulated Navigation Areas (RNA) covering specific bars along the
coasts of Oregon and Washington that will include procedures for
restricting and/or closing those bars as well as additional safety
requirements for recreational and small commercial vessels operating in
the RNAs. The RNAs are necessary to help ensure the safety of the
persons and vessels operating in those hazardous bar areas. The RNAs
will do so by establishing clear procedures for restricting and/or
closing the bars and mandating additional safety requirements for
recreational and small commercial vessels operating in the RNAs when
certain conditions exist.

DATES: The comment period for the proposed rule published on February
12, 2009 (74 FR 7022), is reopened and will close on June 30, 2009. All
comments and related material must be received by the Coast Guard on or
before June 30, 2009.

ADDRESSES: You may submit written comments identified by docket number
USCG-2008-1017 using any one of the following methods:
    (1) Federal eRulemaking Portal: http://www.regulations.gov.
    (2) Fax:<PHONE_NUMBER>.
    (3) Mail: Docket Management Facility (M-30), U.S. Department of
Transportation, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue, SE., Washington, DC 20590-0001.
    (4) Hand delivery: Same as mail address above, between 9 a.m. and 5
p.m., Monday through Friday, except Federal holidays. The telephone
number is<PHONE_NUMBER>.
    To avoid duplication, please use only one of these four methods.
Our online docket for this rulemaking is available on the Internet at
http://www.regulations.gov under docket number USCG-2008-1017. For
instructions on submitting comments, see the ``Public Participating and
Request for Comments'' portion of the SUPPLEMENTARY INFORMATION section
below.

FOR FURTHER INFORMATION CONTACT: If you have questions concerning the
proposed rule, please call or e-mail LCDR Emily Saddler, Thirteenth
Coast Guard District, Prevention Division, Inspections and
Investigations Branch; telephone<PHONE_NUMBER>, e-mail
<EMAIL_ADDRESS>If you have questions on viewing or
submitting material to the docket, call Ms. Renee V. Wright, Program
Manager, Docket Operations, telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Background and Purpose

    We published an NPRM in the Federal Register on February 12, 2009
(74 FR 7022), entitled ``Regulated Navigation Areas; Bars Along the
Coasts of Oregon and Washington.'' On April 13, 2009 (74 FR 16814), we
published a notice of public meetings and the reopening of the comment
period to April 14, 2009.
    In the NPRM, we propose to establish Regulated Navigation Areas
(RNA) covering specific bars along the coasts of Oregon and Washington
that will include procedures for restricting and/or closing those bars
as well as additional safety requirements for recreational and small
commercial vessels operating in the RNAs. The RNAs are necessary to
help ensure the safety of the persons and vessels operating in those
hazardous bar areas. The RNAs will do so by establishing clear
procedures for restricting and/or closing the bars and mandating
additional safety requirements for recreational and small commercial
vessels operating in the RNAs when certain conditions exist.

Public Participation and Request for Comments

    If you submit a comment, please include the docket number for this
rulemaking (USCG-2008-1017), indicate the specific section of this
document to which each comment applies, and provide a reason for each
suggestion or recommendation. You may submit your comments and material
online, or by fax, mail or hand delivery, but please use only one of
these means. We recommend that you include your name and a mailing
address, an e-mail address, or a telephone number in the body of your
document so that we can contact you if we have questions regarding your
submission.
    To submit your comment online, go to http://www.regulations.gov,
select the Advanced Docket Search option on the right side of the
screen, insert ``USCG-2008-1017'' in the Docket ID box, press Enter,
and then click on the balloon shape in the Actions column. If you
submit your comments by mail or hand delivery, submit them in an
unbound format, no larger than 8\1/2\ by 11 inches, suitable for
copying and electronic filing. If you submit them by mail and would
like to know that they reached the Facility, please enclose a stamped,
self-addressed postcard or envelope. We will consider all comments and
material received during the comment period and may change the rule
based on your comments.
    You may view the NPRM in our online docket, in addition to
supporting documents prepared by the Coast Guard, including an
``Environmental Analysis Checklist'' and RNA Fact Sheets for
recreational, passenger, and commercial fishing vessels, and comments
submitted thus far by going to http://www.regulations.gov. Once there,
select the Advanced Docket Search option on the right side of the
screen, insert USCG-2008-1017 in the Docket ID box, press Enter, and
then click on the item in the Docket ID column. You may also visit the
Docket Management Facility in Room W12-140 on the ground floor of the
Department of Transportation West Building, 1200 New Jersey Avenue,
SE., Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through
Friday, except Federal holidays; or the Thirteenth Coast Guard
District, Prevention Division, Inspections and Investigations Branch in
Room 3506 on the 35th floor of the Jackson Federal Building, 915 Second
Avenue, Seattle, WA 98174, between 8 a.m. and 3 p.m., Monday through
Friday, except Federal holidays. We have an agreement with the
Department of Transportation to use the Docket Management Facility.
    We encourage you to participate in this rulemaking by submitting
comments via one of the methods listed under ADDRESSES. All comments
received will be posted without change to http://www.regulations.gov
and will include any personal information you have provided.
    Comments must reach the Coast Guard on or before June 30, 2009. If
you

submit a comment online via http://www.regulations.gov, it will be
considered received by the Coast Guard when you successfully transmit
the comment. If you fax, hand deliver, or mail your comment, it will be
considered as having been received by the Coast Guard when it is
received at the Docket Management Facility.
    Anyone can search the electronic form of comments received into any
of our dockets by the name of the individual submitting the comment (or
signing the comment, if submitted on behalf of an association,
business, labor union, etc.). You may review a Privacy Act notice
regarding our public dockets in the January 17, 2008, issue of the
Federal Register (73 FR 3316).

    Dated: April 27, 2009.
J.P. Currier,
Rear Admiral, U.S. Coast Guard Commander, Thirteenth Coast Guard
District.
[FR Doc. E9-10755 Filed 5-7-09; 8:45 am]

BILLING CODE 4910-15-P